188 related articles for article (PubMed ID: 34379360)
21. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
[TBL] [Abstract][Full Text] [Related]
22. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
23. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
24. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
Biomark Res; 2014; 2():11. PubMed ID: 24963396
[TBL] [Abstract][Full Text] [Related]
25. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract][Full Text] [Related]
26. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
Zhu J; Hu H; Wang J; Yang Y; Yi P
Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
[TBL] [Abstract][Full Text] [Related]
27. miR-144-3p Induces Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells by Targeting Proline-Rich Protein 11 Expression via the Mitogen-Activated Protein Kinase Signaling Pathway.
Li J; Sun P; Yue Z; Zhang D; You K; Wang J
DNA Cell Biol; 2017 Aug; 36(8):619-626. PubMed ID: 28574724
[TBL] [Abstract][Full Text] [Related]
28. The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development.
Wang Y; Zhang Y; Zhang C; Weng H; Li Y; Cai W; Xie M; Long Y; Ai Q; Liu Z; Du G; Wang S; Niu Y; Song F; Ozaki T; Bu Y
Biochim Biophys Acta; 2015 Sep; 1849(9):1133-44. PubMed ID: 26162986
[TBL] [Abstract][Full Text] [Related]
29. Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.
Zhan Y; Wu X; Zheng G; Jin J; Li C; Yu G; Li W
World J Surg Oncol; 2020 Dec; 18(1):318. PubMed ID: 33276775
[TBL] [Abstract][Full Text] [Related]
30. Expression of RNA-binding Motif Protein 3 (
Jang HH; Lee HN; Kim SY; Hong S; Lee WS
Anticancer Res; 2017 Apr; 37(4):1779-1785. PubMed ID: 28373441
[TBL] [Abstract][Full Text] [Related]
31. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer.
Song Z; Liu W; Xiao Y; Zhang M; Luo Y; Yuan W; Xu Y; Yu G; Hu Y
PLoS One; 2015; 10(8):e0128943. PubMed ID: 26252227
[TBL] [Abstract][Full Text] [Related]
32. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
Jonsson L; Gaber A; Ulmert D; Uhlén M; Bjartell A; Jirström K
Diagn Pathol; 2011 Sep; 6():91. PubMed ID: 21955582
[TBL] [Abstract][Full Text] [Related]
33.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
34. PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC).
Zhang C; Zhang Y; Li Y; Zhu H; Wang Y; Cai W; Zhu J; Ozaki T; Bu Y
Biochem Biophys Res Commun; 2015 Mar; 458(3):501-508. PubMed ID: 25666944
[TBL] [Abstract][Full Text] [Related]
35. PRR11 promotes cell proliferation by regulating PTTG1 through interacting with E2F1 transcription factor in pan-cancer.
Zhang H; He Z; Qiu L; Wei J; Gong X; Xian M; Chen Z; Cui Y; Fu S; Zhang Z; Hu B; Zhang X; Lin S; Du H
Front Mol Biosci; 2022; 9():877320. PubMed ID: 36060253
[TBL] [Abstract][Full Text] [Related]
36. The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production.
Dong W; Dai ZH; Liu FC; Guo XG; Ge CM; Ding J; Liu H; Yang F
EBioMedicine; 2019 Jul; 45():155-167. PubMed ID: 31235426
[TBL] [Abstract][Full Text] [Related]
37. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
[TBL] [Abstract][Full Text] [Related]
38. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
Hjelm B; Brennan DJ; Zendehrokh N; Eberhard J; Nodin B; Gaber A; Pontén F; Johannesson H; Smaragdi K; Frantz C; Hober S; Johnson LB; Påhlman S; Jirström K; Uhlen M
Proteomics Clin Appl; 2011 Dec; 5(11-12):624-35. PubMed ID: 21956899
[TBL] [Abstract][Full Text] [Related]
39. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
[TBL] [Abstract][Full Text] [Related]
40. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma.
Chen Y; Cha Z; Fang W; Qian B; Yu W; Li W; Yu G; Gao Y
Oncotarget; 2015 Aug; 6(24):20419-33. PubMed ID: 25971332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
